ArticleRegenerative engineering and translational medicine2025
Silk Fibroin Particle-Laden Sponges as a Multiphase Controlled Release Platform.
Article in Regenerative engineering and translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mechanical and structural responses of silk fibroin scaffolds to MechanoCulture T6® bioreactor loading and enzymatic degradation.Journal of the mechanical behavior of biomedical materials · 2026Article
- Protein Sequence and Structural Diversity inBiomacromolecules · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Purpose: Silk fibroin-based biomaterials have shown utility across regenerative medicine applications due to their ability to provide robust mechanical support and deliver bioactive cargo. To achieve diverse functions, fibroin can be fabricated into material formats with varied morphology including sponge-like scaffolds and microparticles. This study investigates the potential of a dual-component silk fibroin system (particle-laden sponges) to enable two-phase controlled release and assesses the impact of cytokine release on RAW 264.7 polarization. Methods: Silk fibroin microparticles (SFMPs) were prepared through phase separation from PVA before being combined with aqueous fibroin polymer solution at desired mass ratios. This solution was frozen and lyophilized to form a particle-laden sponge. The sponge was then water annealed to induce crystallinity at a set temperature. Sponge morphology was assessed with SEM and crystallinity was assessed with FTIR. Results: Both formulation and temperature during water annealing were found to impact morphology and total crystalline content. Degradation studies showed disruption of the sponge like structures prior to SFMP degradation, indicating a potential for a multiphase controlled release platform. RAW 264.7 cells showed a polarization switch from M1 to M2 in line with hypothesized rates of release from the particle-laden sponge. Conclusion: This study demonstrated the tunability of a dual-component silk fibroin sponge, while also establishing its potential as a multiphase controlled release platform to modulate immune interactions in future
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.